143 related articles for article (PubMed ID: 16453395)
1. Manipulating a journal article.
N Y Times Web; 2005 Dec; ():WK11. PubMed ID: 16453395
[No Abstract] [Full Text] [Related]
2. Medical journal criticizes Merck over Vioxx data.
Berenson A
N Y Times Web; 2005 Dec; ():A1, C13. PubMed ID: 16456990
[No Abstract] [Full Text] [Related]
3. How the New England Journal missed warning signs on Vioxx: medical weekly waited years to report flaws in article that praised pain drug; Merck seen as "punching bag".
Armstrong D
Wall St J (East Ed); 2006 May; ():A1, A10. PubMed ID: 16848016
[No Abstract] [Full Text] [Related]
4. Evidence in Vioxx suits shows intervention by Merck officials.
Berenson A
N Y Times Web; 2005 Apr; ():A1, A32. PubMed ID: 15940861
[No Abstract] [Full Text] [Related]
5. NEJM editor gives pretrial evidence in Vioxx case.
Tanne JH
BMJ; 2006 Feb; 332(7536):255. PubMed ID: 16455704
[No Abstract] [Full Text] [Related]
6. Vioxx doctors wooed by Merck are now its foes.
Tesoriero HW
Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911
[No Abstract] [Full Text] [Related]
7. The lessons of Vioxx--drug safety and sales.
Waxman HA
N Engl J Med; 2005 Jun; 352(25):2576-8. PubMed ID: 15972862
[No Abstract] [Full Text] [Related]
8. Medical journal cites misleading drug research.
Grady D
N Y Times Web; 1999 Nov; ():A18. PubMed ID: 11648133
[No Abstract] [Full Text] [Related]
9. Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research.
Berger E
Ann Emerg Med; 2008 Aug; 52(2):137-9. PubMed ID: 18672488
[No Abstract] [Full Text] [Related]
10. Merck accused of disguising its role in research.
Cressey D
Nature; 2008 Apr; 452(7189):791. PubMed ID: 18431823
[No Abstract] [Full Text] [Related]
11. Merck VIOXX "warning" is questioned.
Allen TS; Henderson JH
Tex Med; 2005 May; 101(5):5-6. PubMed ID: 15948521
[No Abstract] [Full Text] [Related]
12. Open conflict on the handling of the Merck drug Vioxx by editorial giants.
Edwards RG
Reprod Biomed Online; 2006 Dec; 13(6):905. PubMed ID: 17169217
[No Abstract] [Full Text] [Related]
13. Lapses at the new England journal of medicine.
Smith R
J R Soc Med; 2006 Aug; 99(8):380-2. PubMed ID: 16893926
[No Abstract] [Full Text] [Related]
14. Ghost story: at medical journals, writers paid by industry play big role.
Mathews AW
Wall St J (East Ed); 2005 Dec; ():A1, A8. PubMed ID: 16506304
[No Abstract] [Full Text] [Related]
15. Researchers raise concerns about secrecy in company-sponsored clinical trials.
Mangan KS
Chron High Educ; 2006 Apr; 52(31):A29. PubMed ID: 16789295
[No Abstract] [Full Text] [Related]
16. Despite warnings, drug giant took long path to Vioxx recall.
Berenson A; Harris G; Meier B; Pollack A
N Y Times Web; 2004 Nov; ():A1, A32. PubMed ID: 15599982
[No Abstract] [Full Text] [Related]
17. Scientific publishing. Echoing other cases, NEJM says Vioxx Safety data withheld.
Couzin J
Science; 2005 Dec; 310(5755):1755. PubMed ID: 16357236
[No Abstract] [Full Text] [Related]
18. Research dishonesty and conflict of interest.
Frizelle F
N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
[No Abstract] [Full Text] [Related]
19. Failing the public health--rofecoxib, Merck, and the FDA.
Topol EJ
N Engl J Med; 2004 Oct; 351(17):1707-9. PubMed ID: 15470193
[No Abstract] [Full Text] [Related]
20. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
Tereskerz PM
Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
